Results 211 to 220 of about 25,852 (233)
Some of the next articles are maybe not open access.
Progress in Platelet Blockers: The Target is the P2Y12 Receptor
Journal of Cardiothoracic and Vascular Anesthesia, 2013The considerable progress in P2Y12-platelet blockers has important perioperative implications due to a family of novel agents beyond clopidogrel. Although prasugrel is more potent than clopidogrel due to more efficient hepatic metabolism, it is limited clinically by its irreversibility and bleeding risks.
Prakash A, Patel +2 more
openaire +2 more sources
Potent P2Y12 Inhibitors and Bleeding Complications
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2022Ahmet, Güner +4 more
openaire +2 more sources
Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLD
Cancer Cell, 2022Chi Ma, Laurence P Diggs, John C Mcvey
exaly
Involvement of P2Y12 receptors in a nitroglycerin‐induced model of migraine in male mice
British Journal of Pharmacology, 2021Flora Gölöncsér +2 more
exaly
Platelets Express Activated P2Y 12 Receptor in Patients With Diabetes Mellitus
Circulation, 2017Liang Hu, Si Zhang, Hongmei Yan
exaly
Vessel wall, not platelet, P2Y12 potentiates early atherogenesis
Cardiovascular Research, 2014Laura West +2 more
exaly
Microglial P2Y12 receptors regulate microglial activation and surveillance during neuropathic pain
Brain, Behavior, and Immunity, 2016Ukpong B Eyo +2 more
exaly